Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.38% | 54.97% | 57.33% | 44.81% | 67.68% |
| Total Depreciation and Amortization | -100.00% | -50.00% | -66.67% | -33.33% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -96.00% | -73.08% |
| Total Other Non-Cash Items | -5.33% | -76.87% | -77.24% | -66.76% | -86.15% |
| Change in Net Operating Assets | 43.61% | 50.14% | 56.10% | 131.66% | 114.52% |
| Cash from Operations | 64.97% | 49.84% | 45.56% | 33.59% | 20.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 253.33% | 300.00% | 218.75% | 307.14% | 7.14% |
| Cash from Investing | 253.33% | -61.45% | -69.28% | -65.24% | -90.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 80.00% | 80.00% | 50.00% | -400.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 80.00% | 80.00% | 50.00% | -400.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.81% | -25.81% | -89.47% | -155.13% | -406.06% |
